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ABSTRACT 
Infection with enterotoxigenic Escherichia coli (ETEC) is a leading cause of 
diarrhea in children in developing countries and travelers to endemic regions. 
ETEC is a diverse pathogen, with a wide range of virulence factors including 
enterotoxins and more than 25 identified colonization factors (CFs). ETEC 
infection causes varying symptoms (mild to profuse, watery, cholera-like 
diarrhea) as a result of the colonization of the small intestine via CFs, secretion 
of heat labile (LT) and/or heat stable enterotoxins (STp and STh). 
To expand the knowledge about the complexity of ETEC pathogenesis we 
studied the genetic diversity of the LT and ST toxins, using a clinical ETEC 
strains collection isolated worldwide during three decades. By genomic 
sequencing we found high diversity in the toxin amino acid sequences, especially 
in LT where 20 amino acid variants were identified. The LTA subunit was highly 
polymorphic while the LTB subunit was more conserved. The most common LT 
variants were LT1 and LT2. ST was less heterogeneous, including 3 ST alleles 
found in STp and 3 in STh. Phylogenetic analysis of the toxins revealed 
worldwide distribution of the different variants, and an association with specific 
CF profiles. The most frequent toxin variants belonged to ETEC linages that 
have disseminated globally over decades. We also found that main variants 
differed in ability to produce and secrete the toxins. The STp variant STa5 was 
linked to disease in adults while the STh variant STa3/4 was associated with 
disease in children. 
The gene expression levels of LT (eltAB), and ST (estA) were analyzed by 
qPCR. We found significantly lower levels of eltAB in presence of glucose in LT1 
strains. No polymorphisms were found at the CRP binding sites at eltAB 
promoter.  ST alleles were also significantly downregulated by glucose while bile 
supplementation favored STp expression.  
Finally, we performed an RNA-transcriptome study, which showed a 
dramatic change in global gene expression at the onset of stationary phase. 
During a specific transient phase we observed up- and down-regulation of genes 
involved in mechanisms related to virulence, such as biofilm formation, indole 
induction, iron uptake, fucose catabolism, and the putrescine pathway. The 
expression levels of the toxins and CFs remained high during this phase. 
Altogether, this study highlights the diversity within the ETEC population 
and its virulence factors. We propose that certain combinations of virulence 
genes influence strain specific responses to host factors that may impact the 
pathogenesis and severity of ETEC infections. 
ISBN 978-91-628-9508-2 
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INTRODUCTION                                                                                                                                                    
  
Commensal and pathogenic Escherichia coli 
In humans, the gastrointestinal tract is home to an extraordinary diversity 
of bacterial species including Escherichia coli (E. coli). E. coli was first thought to be 
the predominant commensal bacterial species in human gut, however it was 
later confirmed that it only comprises 0,1% of the total gut flora, which is 
dominated by obligate anaerobic bacteria [1]. E. coli is a facultative anaerobic 
gram-negative bacterium that is usually harmless but it can cause disease by 
acquisition of mobile elements such as pathogenicity islands (PAIs) and 
plasmids as well as bacteriophages and transposons integrated into either the 
bacterial chromosome or plasmid [2]. As such, every pathogenic form of E. coli 
(pathovar or pathotype) share and display a set of common virulence factors to 
cause a common disease. However, single strains of each pathotypes can 
different sets of virulence markers that define the severity of the disease[2, 3].  
Different pathotypes of E. coli have found to cause a wide range of human 
diseases by colonizing the gastrointestinal tract (diarrheagenic E. coli, DEC) or 
disseminated along the urinary tract, bloodstream and central nervous system 
(extraintestinal E. coli, ExPEC). DEC comprises six different pathotypes: entero-
pathogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), enterohemorrhagic E. 
coli (EHEC), enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC), and 
diffusely-adhering E. coli (DAEC) [2, 3].  
Worldwide, DEC is the major cause of diarrheal disease, which remains a 
leading cause of morbidity and mortality in children under 5 years of age [2]. 
DEC strains are also associated to numerous outbreaks of diarrheal cases among 
travelers. Some pathotypes have a major impact on the global health burden of 
diarrhea disease, especially in developing countries [4].  
Enterotoxigenic Escherichia coli (ETEC) 
Among DEC pathotypes, ETEC alone accounts for millions of diarrheal 
episodes and it is one of the major agents of moderate to severe infantile 
diarrhea in developing countries [4]. 
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ETEC is estimated to be the second biggest cause of diarrheal disease in 
children in developing countries, who experience a median of 3,2 episodes of 
diarrhea/child-year. ETEC infections are also responsible for fatal cases of 
diarrhea. Annually, approximately 300,000-500,000 deaths in children in 
endemic regions are reported. ETEC also commonly cause diarrhea in travelers 
to endemic regions in Africa, Asia and Latin America [5, 6].  
ETEC is also considered as an important emerging cause of food-borne [7] 
and water-borne disease [8] with negative health and economic consequences in 
both developed and developing countries [7]. ETEC is transmitted through the 
fecal-oral route by ingestion of contaminated food and drinking water exposed to 
human sewage. Ingested ETEC can reach the human intestinal tract, colonize 
and then cause diarrhea by deregulation of ion channels in the epithelium [2]. 
The clinical manifestation of an ETEC infection ranges from mild diarrhea 
without dehydration to severe cholera-like disease [9].  The infection dose is 
considered to be approximately 108 colony-forming units (CFUs) with an 
incubation period between 15-50 h after ingestion of the bacteria [10]. ETEC 
infections have been found to be directly related to delayed growth and 
malnutrition that increase the susceptibility to acquire another ETEC infection 
during the first years of life [11]. The disease is usually self-limited in 1 to 5 days 
and in few cases prolong beyond 10 days [11, 12]. 
Virulence and Pathogenesis of ETEC 
Classical and non-classical virulence genes 
ETEC is a complex and heterogeneous pathogen with a genome size of 
approximately 4,8 to 5,2 Mbp including several plasmids [13, 14].  It harbors 
virulence genes and putative virulence genes involved in different mechanisms of 
pathogenicity leading to diarrhea. In order to cause diarrhea, ETEC express and 
produce either one or both of two well characterized plasmid-encoded 
enterotoxins, the heat labile enterotoxin (LT) and the heat stable enterotoxins 
(ST), and up to 25 antigenically different, mainly also plasmid-encoded 
colonization factors (CFs) [15].  
Some ETEC virulence-related plasmid and chromosomal-encoded genes 
have also been involved in the outcome of infection. These non-classical 
virulence determinates have been found to be located on the chromosome, 
pathogenicity islands and in plasmids [16, 17]. TibA is an example of 
chromosomally encoded adhesin that mediates adhesion to human cells and 
subsequently induces invasion [18]. Another chromosomal gene, clyA encodes a 
! ! 13!
pore-forming hemolytic protein and its expression leads to cytotoxic effects on 
mammalian cells [19]. The tia and leoA genes, on the contrary, are harbored on 
pathogenicity islands. Tia is an outer membrane protein acting as an adhesin [20], 
while LeoA is involved in toxin secretion by membrane vesicles [21]. The plasmid 
gene eatA, encodes a serine protease that degrades the major protein on the 
mucosa layer of the small intestine and facilitate translocation of toxins [22]. The 
EtpA extracellular adhesin is also a plasmid-encoded protein that is located on 
the tip of the flagella and is required for optimal delivery of LT to epithelial cells 
[23]. In addition, a large diversity of more than 100 different O antigens is 
attributed to ETEC strains collected from different countries around the world. 
In early studies, serotyping was a used to identify and characterize ETEC strains 
until molecular techniques using virulence markers as targets were applied to 
improve diagnostic sensitivity [11]. 
Thus, ETEC´s heterogeneity is made up not only of different combinations 
of toxins and CFs but also by the expression of other distinct virulence 
determinants located on the bacterial chromosome or extra chromosomal DNA, 
and generally transmitted by horizontal gene transfer (HGT). It is evident that 
any individual ETEC strain only harbor a subset of the virulence genes and 
putative virulence markers mentioned above which might affect virulence. The 
hallmark of ETEC is however the expression of one or both of the two major 
toxins LT and ST. 
Enterotoxins: heat labile (LT) toxin and heat stable (ST) toxin  
ETEC is though to have evolved when nonpathogenic E. coli acquired 
virulence plasmid (s) [14, 24]. The transition from commensal bacteria to a 
pathogenic form causing millions of deaths of people was driven by acquisition 
of the two LT and ST enterotoxins [25]. The LT and ST genes were probably 
acquired by E. coli from Vibrio cholerae in the remote past (~ 130 millions year 
ago), long before the origin of the genus Homo suggesting that in the beginning 
the niche of ETEC was the environment and that the toxins initially had other 
purposes [26]. New ETEC clones have however evolved independently at several 
occasions [27]. The current pandemic ETEC clones seem to have emerged rather 
recently 50-150 years ago [24]. 
The toxins are ligands to receptors expressed in the human small intestine. 
Once enterotoxins are liberated into the intestinal tract, they specifically interact 
with the gastrointestinal mucosa by binding to their receptors and interfere with 
signal transduction pathways leading to imbalance in intracellular homeostasis 
[28]. The LT toxin comes in different variants, LTI and LTII where LT-I is 
associated with disease in both human and animals while LT-II has been 
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associated only with animal disease. Several variants of the heat stable toxin do 
exist in pathogenic E. coli infection in both animals and humans and are termed 
STa or STI and STb or STII. ETEC strains infecting human produce the STa and 
LT-1 variants, which are the only toxin variants thought to play an important 
role in human disease [11] and the focus of this thesis. 
Human heat- labile toxin (LT- I) 
In 1991, the crystal structure of LT was elucidated and the multimeric AB5 
conformation of the toxin was revealed, typically found in members of the AB5 
toxin family [29]. Other bacterial toxins are also belong to this large family, 
including Shiga toxin, Pertussis toxin, Anthrax toxin, Ricin, and Cholera toxin 
(CT) [30]. LT is closely related to CT and shares similar physiology, structure and 
antigenic properties [9]. 
LT is encoded by the eltAB operon composed by two genes, eltA (LTA) and 
eltB (LTB), which have a 4 nucleotide overlap in the nucleotide sequence. The 
eltAB sequence has an identity of approximately 80% with the ctxAB sequence 
encoding CT and both toxins have totally 240 amino acids [31, 32]. 
As is shown in Figure 1, the holotoxin structure of LT is organized in two 
subunits: LTA and LTB. The single LTA subunit has a catalytic domain with 
ADP-ribosylation activity and binds to a pentamer of non-toxic B subunits 
(LTB). The LTB pentamer binds to glycosphingolipid receptors on the surface of 
eukaryotic cells (e.g., GM1 gangloside). The LTA subunit is basically divided into 
a large A1 domain with the enzyme-active site, which is linked to a small A2 
domain responsible for embedding the LTA1 subunit into the center of the LTB 
pentamer. A single trypsin-sensitive loop and a long α-helix join the two 
subunits. The molecular masses for subunit A and B is 27,200 and 11,800 Da, 
!
Figure 1. The crystal structure of the human heat labile toxin (LT).  
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respectively [9, 32, 33]. Several steps are necessary for the toxin production and 
uptake to be able to trigger the diarrhea in the host [31, 34, 35] (Figure 2 and 3).  
Diversity of heat labile toxin 
In early studies the molecular heterogeneity of LT was assessed by analysis 
of the electrophoresis properties and immunological studies. Honda et al. [36] and 
Tsuji et al. [37] first desribed that the LT-1 toxins found in porcine infections 
(LTp) and human LT (LTh) were similar but not identical. These observations 
raised the question of differences between LTs at the sequence level. After 
sequencing of LT gene derived from ETEC from human and porcine origins it 
was possible to show that they share 95% identity but have some polymorphic 
amino acids in their sequences of the A subunit (K4R, K213K and N238D) and 
the B subunit (S4T, A46E, and E102K) [38, 39]. By applying discriminatory 
techniques i.e. RFLP it was possible to distinguish LTp and LTh through 
differences in a single HhaI restriction site [40]. This technique was used to test 
several ETEC isolates from different sources and to characterize LT types when 
DNA sequencing was not accessible and affordable. However, during the last 
decade the dramatic reduction in cost has made sequencing more accessible for 
all labs and therefore it has been possible to include more ETEC LT strains and 
analyze the natural diversity of this toxin. As a result of the sequencing of the 
LT-I gene from human derived-ETEC strains isolated from a restricted 
geographic region (Brazil), 16 LT variants were found. This finding provided a 
new perspective about the heterogeneity of LT [41]. In our recent study (Paper I) 
that examined amino acid polymorphisms from a geographic and temporal 
diverse set of 192 LT human-ETEC strains, 20 different LT variants were found, 
including 8 previously described in Lasaro´s study and 12 novel variants [42]. 
Altogether, these studies provided new insights about the remarkable diversity 
harbored in human derived-ETEC and its enterotoxins and also indicate a link 
with the phenotype heterogeneity of the disease.  
Heat stable toxin (STa) 
ETEC isolates can express two distinct heat-stable toxin families, STa, STA, 
STI, or ST1 and STb, STB, STII, or ST2 with significant differences in structure, 
function, antigenic cross-reactivity, methanol solubility and activity in infant 
mouse [10]. STa found in human isolates is a small cysteine rich enterotoxin of 
18-19 amino acids. Three cysteine-based disulfide bonds link the peptide into a 
small molecule with a molecular mass of ca. 2 kDa. STa is encoded on a plasmid 
by a transposon associated estA gene. Within STa, two variants associated with 
human disease have been described, STh and STp, originally found in human 
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and pigs, respectively. STp and STh are synthetized as 72-amino acid residues 
including a pre -or signal peptide, a pro region and a mature ST region. ST is 
active even after 60 min of heating at 95°C. STa also has to go through different 
steps until it reaches the target and cause diarrhea (Figure 2 and 3)[10, 28, 33, 43-45]. 
Diarrhea induced by STa is of the secretory type with no signs of 
inflammation or colon involvement [45]. It also probably induces more severe 
disease than LT among children in developing countries [46]. A recent study 
demonstrated that ST is responsible for the rapid onset and shorter duration of 
ST-induced diarrhea, while if a LT+/ST+ ETEC strain is causing the diarrhea 
episode, a second phase with longer duration is due to LT-induced diarrhea [47]. 
 Diversity of heat stable toxin 
ST comprises a family of small cysteine-rich peptides that cause diarrhea in 
human and animals. Peptides with a high homology to E. coli STa have been 
found in other bacterial pathogens such as Yersinia enterolitica, Citrobacter freudii, 
cholera toxin positive Vibrio cholerae O1 and Klebsiella pneumonia. Within the DEC 
group, the enteroaggregative heat-stable toxin EAST1 encoded by the gene astA 
in EAEC strains has a 117-bp-long DNA sequence and belongs to a subfamily of 
heat stable toxins and it is genetically and immunologically distinct from ETEC 
STa [48]. 
Also three endogenous peptides display functions similar to ST: 
uroguanylin, guanylin and lymphoguanylin which has 16, 15 and 15 amino 
acids, respectively. The function of these peptides is to maintain normal fluid 
and electrolyte homeostasis in the kidneys and intestine. This explains how STa 
can deregulate fluid homeostasis in the human gut since STa and the 
endogenous molecules share the same receptor, the guanylate cyclase C (GCC) 
[44]. 
STb is encoded by estB gene and it was mostly associated to porcine strains 
than can also harbor the STa gene. STb has shown little heterogeneity and one 
natural variant has been reported. The STb gene is present in combination with 
STa and teracycle resistance gene, possibly in the same plasmid [49].   
In contrast to STb, STa is a family that is more heterogeneous since several 
natural variants were identified. In early studies, the first variant identified 
designated estA1 was the porcine type of ST (STp) with an 18 amino acid length 
sequence in comparison with the STh amino acid sequence of 19 aa [50]. Follow-
up studies demonstrated the presence of three additional STa variants identified 
as estA2 (STa2), estA3 (STa3) and estA4 (STa4)[50-54].  
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Figure 2. Mechanisms of synthesis and secretion of LT and ST.  
LT: 1. Synthesis of LTA and LTB as precursors with signal peptides, which are transported 
across the cytoplasmic membrane to the periplasm. 2. Periplasmatic proteolysis of the signal 
peptides of mature subunits. 3. By releasing mature subunits into the periplasm, the 
holotoxin assembly is mediated by the pentamerization of LTB in a circular conformation, 
which embeds the C-terminal tail of the LTA2 domain. Pentamerization also can occur in 
either absence of LTA or preformed LTB pentamers. However, in presence of LTA the 
assembly process is three times faster promoting stability. 4. Secretion of the assembled 
subunits by the type II secretion (T2SS) apparatus.  
ST: A. Synthesis of STa as an intracellular pre-pro-STa with subsequent cleavage of the 19 
amino acid signal sequence by a signal peptidase during or after translocation across the 
inner membrane. B. Translocation to the periplasm and formation of intracellular disulfide 
bonds by a SecA-dependent export pathway establishing the three-dimensional structure of 
the peptide. C. Inside the periplasm DsbA cleaves the 53-amino acid pro-STa leaving the 
mature STa to be secreted through the TolC channel.  
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Figure 3. Pathogenesis of ETEC infection.   
LT: 5. Recognition and binding of the pentameric complex of LTB monomers to receptors 
GM1 on the epithelial cell membrane. 6. Internalization of toxin prior activation. 7. 
Association of GM1 receptors with lipid rafts inserted in the cell membrane mediates toxin 
endocytosis. 8. Toxin trafficking via retrograde manner to the endoplasmic reticulum (ER) 
and translocation of LTA1 subunit to the cytoplasm. 9. Toxin activation is undertaken by two-
step process: nicking and reduction. The photolytic processing using trypsin-like enzyme 
between amino acids 192 and 193 leads to activation and formation of activated LTA1 
domain. The LTA2 domain, at the same time, still keeps linked to a B pentamers. 10. 
Activation of G protein Gsα by LTA1 stimulates adenylate cyclase to produce cAMP resulting 
in a dramatic efflux of ions and water from the host leafing to watery diarrhea. AC: Adenylate 
cyclase. PKA: protein kinase. ST: The biological active STa which mimics the hormone 
guanylin and binds to the extracellular domain of guanylyl cyclase C (GC-C) receptors widely 
present in the brush border membranes of the intestinal epithelium. 5. Consequently, the 
catalytic domain of GC-C is activated which leads to increased levels of intracellular cyclic 
GMP, stimulating chloride secretion through cystic fibrosis transmembrane receptor (CFTR) 
and/or preventing NaCl absorption. 6. The result is net fluid accumulation into the intestinal 
lumen and secretory diarrhea. 
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The three new variants that belongs to the STh type were found to be 
>90% identical to each other at the amino acid sequence level with all of the 
polymorphic sites located at the pro region of ST. In a more recent study [51], by 
resequencing of estA3 and estA4 genes, the STa4 variant was discarded as a new 
variants, since it was found to be identical to estA3. We have analyzed additional 
STa positive ETEC strains and found three novel alleles, which are discussed in 
this thesis (Paper II). 
Adherence mediated by expression of colonization factors (CFs) 
In order to perform an effective delivery of its enterotoxins, ETEC colonize 
the small intestine as an initial step of its pathogenesis by means of plasmid-
encoded fimbrial colonization factors (CFs) [55, 56]. CFs include a variety of pilus 
(fimbrial) or pilus-related adhesins and up to 25 different CFs have been 
described and putative new CFs are repeatedly discovered [57, 58]. In early studies, 
an ambiguous nomenclature was used to designate the different CFs; years later 
it was improved and standardized [55] giving a “CS” (Coli Surface antigen) 
designation, followed by an Arabic numeral, excepting CFA/I.  CFs are pili with 
polymeric structures and conformed by either single (homolymeric) or more 
than one structure subunit (heteropolymeric) [58]. Based on the morphology, 
four main types were described including the well-described CFs: fimbrial 
(pilus) (CFA/I, CS1, CS2, CS4, CS8, CS12, CS14, CS17-21, CS26), fibrillar 
(CS3, CS11, CS13, CS22) helical (CS5, CS7) and afimbrial (CS6, CS10, CS15, 
CS23) [11, 58, 59]. Although epidemiologic studies have reported CFA/I, CS1-7, 
CS14, CS17 and CS21 to be most common in ETEC globally, almost 30-50% of 
ETEC strains are lacking of any characterized CF [11, 60].   
The CF genes are genetically organized in operons, including all genes 
needed for the assembly of functional CFs. Thus, due to their plasmid 
localization, it is suggested that ETEC acquired the whole operons by horizontal 
gene transfer.  For instance, CFA/I and CS1 are harbored by pCS1 [61] and pCoo 
[62] conjugative plasmids, respectively. Remains of insertion sequences flanking 
the pilus operons indicate mobilization of these genes via transposition [58]. 
CFs differ in receptor-binding specificity even though the natural intestinal 
receptor molecules for ETEC CFs are still largely unknown. They are able to 
hemagglutinate and attach to the intestine through binding to specific receptors, 
such as glycoproteins and glycosphingolipids [58]. Also, Lewis blood group “a” 
antigen have been associated to symptomatic infection with ETEC strains 
expressing a variety of CFs, particularly the Lewis blood group Lt (a+b-) was 
strongly associated with infection by ETEC expressing CFA/I [63]. 
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Type II secretion system (T2SS) and its role in the secretion of LT 
Enteropathogens have evolved and acquired specific mechanisms that 
enable them to colonize and proliferate by producing damage to the host in the 
process causing disease. ETEC delivers enterotoxins and proteases to the 
intestinal lumen by secreting them through a complex secretion system widely 
present in gram-negative species, the type II secretion system (T2SS) [64]. It is 
considered as a virulence factor because of its role in the secretion of LT [65]. 
Also other human pathogens have shown to harbor one or more T2SSs including 
Vibrio cholerae [66], EHEC, Klebsiella spp and Legionella pneumophila [64].  
The type II secretion system is a sophisticated multiprotein machinery 
formed by 12-16 proteins that spans the inner and outer membrane leading to 
the controlled liberation of specific folded proteins and virulence factors directed 
to the periplasm through the Sec machinery [65, 67, 68]. The genetic structure of 
T2SS is arranged in a major operon composed of genes gspC, -D, -E. –F, -G, h-H, -I, 
-J, -K, -L, -M, -N and –O (gspC-O) and in some cases a minor operon containing 
gspA and gspB that codes for surface protein and a large serine-rich glycoprotein, 
respectively or an independently encoded gspS [64, 68, 69]. 
Genomic sequencing of the ETEC H10407 lab strain allowed identification 
of the presence of two T2SS operons encoded in the bacterial chromosome 
homologous to that used by V. cholerae to secrete CT [67]. The two distinct gsp-
operons were designated alpha (T2SSα) and beta (T2SSβ). While T2SSβ is 
assembled and functionally active in LT secretion into the culture supernatant 
under standard laboratory conditions, T2SSα under the exactly same conditions 
is not assembled, probably due to the repression of the gspABα and gspC-O 
promoters by a global regulator H-NS [70]. Most likely T2SSα required specific in 
vivo or environmental conditions to be expressed. In contrast of H10407 and 
TW10598 ETEC strains that contains both secretion system, ETEC strains such 
as E24377A and B74 are lacking T2SSα, indicating that T2SSα is not involved in 
the secretion of LT in all ETEC strains [69]. In addition, sequencing data indicated 
that T2SSα is not conserved among other enteropathogens whereas T2SSβ is 
prevalent among them (ETEC, AIEC, EPEC, EAEC, UPEC, APEC and ExPEC) 
[71].  
The structure of the T2SS suggests that this multiprotein complex consists 
of four parts: an inner membrane platform, a periplasmic pseudopilus, an outer 
membrane complex and the cytoplasmic secretion ATPase as is represented in 
Figure 4. The inner membrane platform consists of proteins GspC, F, L and M, 
forming the core of the system that interact with the pseudopilus (major 
pseudopilus GspG and minor pseudopilins GspH, I, J and K) the secretin (GspD) 
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and the cytoplasmic ATPase (GspE). The inner-membrane complex might have a 
key role in converting conformational changes in the ATPase into extension of 
the pseudopilus, which possibly acts as a piston and that pushes exoproteins 
through the outer-membrane channel [64, 72].  
 GspC may regulate T2SS substrate specify though its homology region 
(HR) domain and PDZ (post synaptic/Drosophila/zonula occludens-1 protein) 
domain. Also, GspC acts as a tether between the outer membrane complex 
composed of GspD and the inner membrane complex [73]. GspE is a Zn-
containing secretion ATPase, which probably forms hexamers at the interface 
with the inner membrane. Although the mechanism in which GspE powers the 
T2SS is unknown, it might couple energy derived form ATP hydrolysis to drive 
assembly/disassembly of the pseudopilus since GspE interacts with GspL which 
in turn interacts with the major pseudopilin GspG [74]. In absence of the ATPase, 
T2SS is not functional; therefore GspG has an essential function for T2SS [75].  
The periplasmic pseudopilus (GspG, H, I, J and K) is designated as a 
pseudo-pilus due to the sequence identity with pilins of the Type I. GspK 
together with GspI and GspJ may form the “arrow head” of the pseudopilus 
whereby GspK may interact with secretin or substrates of the T2SS [76]. 
The outer membrane part of the complex contains for 12-14 subunits of the 
GspD, which is termed the secretin. It belongs to the outer membrane secretin 
transporters and its function is to act as the outer membrane pore through 
which proteins are translocated [69]. 
 
Figure! 4.! The! type! 2! secretion!
system!(T2SS)!in!ETEC.!The!system!is! formed! by! the! ATPase! in! orange,!the!inner>membrane!proteins!with!a!transmembrane! helix! colored! in!purple,! the! outer>membrane!proteins!are!colored! in!blue!and! the!pili! in! pink.! OM,! outer! membrane;!IM,!inner!membrane!
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In later studies on the T2SSβ operon, three atypical genes (yghJ, pppA, and 
yghG) upstream of gspC were found [70]. The yghJ gene encodes a putative 
lipoprotein, homologous to the accessory colonization factor (AcfD) of V. 
cholerae, and also essential for colonization in mouse. It is not a structural 
protein of the T2SS since it is secreted to the culture supernatant. YghJ is also 
identified as a mucinase that cleaves MUC2 and MUC3 present in the small 
intestine and is also known as SslE [77]. The pppA gene encodes prepilin 
peptidases required for processing of pseudopilin subunits GspG-K. Deletion of 
this gene does not affect assembly of the secretin multimer and does not prevent 
secretion of LT [69, 70]. The third gene yghG located directly upstream of gspC 
encodes an outer membrane lipoprotein. Deletion of yghG prevents assembly of 
GspD secretin, which results in a nonfunctional T2SS and inability to secrete LT 
[69, 70]. 
Vesicles secrete LT 
Although both LT and CT are secreted through the outer membrane via the 
general secretion pathway, some authors have found that a portion of LT 
remains associated to the outer membrane of ETEC whereas CT is completely 
secreted from V. cholerae. Comparison between LPS between ETEC and V. 
cholerae revealed that two unphosphorylated D-manno-octulosomic acid (Kdo) 
bound to lipid A was present in ETEC LPS while in V. cholerae LPS contained a 
single phosphorylated Kdo. Later, it was demonstrated that LT is only able to 
bind to Kdo molecule that are not phosphorylated [78]. It was described that 
when LT is bound to outer membrane vesicles (OMV), it acts as an adhesin by 
mediating the internalization of ETEC vesicles into the intestinal epithelial cells. 
The molecular delivery of LT begins when the LT-bound vesicles either bind to a 
receptor in a lipid raft such as caveolin prior internalization and retention and 
finally LT is trafficked to the Golgi and ER [79].  
Similar mechanism of virulence factors delivered by pathogen-derived 
vesicles also has been described in other pathogens, for instance Shiga toxin was 
found associated with vesicles from E. coli O157:H7 strain [80]. H.pylori is another 
example where the vacuolating toxin VacA is associated to vacuoles and 
transported through lipid raft [81]. In Vibrio cholerae, a pore forming toxin called V. 
cholerae cytolysin (VCC) is also translocated to the eukaryotic cell by OMVs [82]. 
Based on these observation and additional studies the mechanisms of secretion 
of LT by OMVs produced by ETEC might be an alternative route where LT can 
be delivered into the host and might play a role in virulence of ETEC.  
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Transcriptional Regulation in Escherichia coli 
Bacteria are microorganisms with a very complex but at the same time 
efficient mechanism to respond to external stimuli by modifying their genome 
expression pattern. A major step of regulation of the gene expression is the 
transcription initiation [83-85].  
The principal component during transcription is RNA polymerase (RNAP), 
which is a holoenzyme, comprised of a multi-subunit core enzyme with subunit 
composition α2ββ’ω, and one of the seven known sigma factor σ subunits with 
promoter recognition activity. The recognition of promoters by RNAP 
holoenzyme is determined by the type of associated sigma (σ) factor. The order 
of transcription level is determined by the strength of the promoter and it is 
significantly affected by the presence of the upstream (-35 to -65) region of the 
promoter, which encompass the UP element, a binding site for the C-terminal 
domain of the α-subunit of RNA [83, 86, 87]. However, the promoter strength 
undergoes modification by the second set of regulatory protein, so-called 
transcriptional factors. They modulate at transcriptional level from the promoter 
by a direct interaction with the target DNA, located close to the promoter. The 
transcriptional apparatus is formed once the DNA-binding transcription factors 
interact with DNA-bound RNA polymerase subunits. This interaction also can 
involve changes in the DNA curvature. The distribution, concentration and 
activity of each transcriptional factor are influenced by external signals and 
internal metabolic states [83, 87]. 
Transcription factors 
The classification of the TFs is based on at least two domains, which allow 
them to act as regulatory switches and divided in several families. The two-
domain structure contains a signal sensor domain and a responsive domain. The 
signal sensor is characterized by a ligand-binding or protein-protein interaction. 
More often the ligand is a metabolite or a physical or chemical signal that 
channels the information, which is either endogenous or environmental. The 
responsive domain directly interacts with the target DNA sequence or 
transcription factors-binding sites (TFBSs). In some cases TFBSs exist as direct 
repeats or palindromes and are located at various positions, from far upstream to 
inside or downstream of the promoter, depending the canonical -35 and -10 
promoter sequences [88, 89]. In E. coli the domain more representatively found is 
the helix-turn-helix domain [90].   
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The role of the TF can be summarized by repression or activation of the 
transcription. The repression mechanism is characterized by binding to the 
promoter and consequently interfering with RNA polymerase. Three 
mechanisms of repression have been described [88, 91] in Figure 4.  
In contrast, some others act as positive regulators and bind to the region 
upstream the promoter, helping in the recruitment of the polymerase to star the 
transcription. Similar to the repression mechanism, three mechanisms for a 
simple activation have been proposed [88, 91] in Figure 5.  
!
Figure!4.!Different!mechanisms!of!
repression!in!prokaryotes!
a) Repression steric hindrance. The 
repressor-binding site overlaps 
core promoter elements and 
blocks recognition of the 
promoter by the RNA 
polymerase holoenzyme. 
b) Repression by looping. Repressor 
binds to distal sites and interact 
by looping, repressing the in-
tervening promoter. 
c) Repression by modulation of an 
activator. The repressor binds to 
an activator and prevents the 
activator from acting by 
blocking promoter recognition 
by the RNA polymerase 
holoenzyme.  !!
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Overview of Global Regulators 
Global regulators are characterized for displaying pleiotropic phenotypes 
and their ability to regulate operons involve in different metabolic pathways [92]. 
Interestingly, seven regulatory proteins (CRP, FNR, IHF, FIS, ArcA, NarL and 
Lrp) are able to modulate the gene expression of more than 50% of genes in E. 
coli [91] and an overview of their main features is described as follows.  
Figure 5. Different mechanisms of activation in prokaryotes 
a) Class I activation. The activator binds to a target at -35 element to recruit 
RNA polymerase to the promoter trough direct interaction with the RNA 
polymerase αCTD.  
b) Class II activation. The activator binds to the target, which overlaps the 
promoter -35 element to contact the domain 4 of the RNA polymerase, 
leading the recruitment of RNA polymerase into the promoter. 
c) Activation by conformation change. It is mediated by alteration of the 
conformation of the target promoter to help the interaction of RNA 
polymerase with the promoter -10 and/or -35 elements. 
 
!!
!
! ! 26!
In the first level of hierarchy the cAMP repressor protein, CRP, acts as a 
master regulatory protein. It is in charge of sensing the energy available for the 
metabolism by cAMP levels. CRP is by far the TF that regulate the most TFs, 
including itself. This global regulator will be described in more detail below. 
FNR (fumarate and nitrate reductase) and ArcA (aerobic respiration control 
protein) are responsible of the direct regulation of energy production by 
modulating respiratory modes. FNR is a oxygen level sensor through an iron-
sulphur cluster at the N-terminus of the protein and synchronize the 
transcriptional response to oxygen limitation [87]. ArcA is a member of the two-
complement regulatory system for regulation of expression of genes encoding 
enzymes involved in mainly anaerobic catabolic pathways [93]. The leucine-
responsive protein (Lrp) is involved in the activation of anabolism and 
repression of other catabolic pathways; helping to the bacterium to adapt to 
changes in the nutritional environment [94]. Fis (factor for inversion 
stimulation), IHF (integration host factor) and Hns (histone-like nucleotide 
structuring protein) are DNA-binding proteins and act as sensors of cellular 
energy levels by modulating the DNA topology. They are nucleoid-associated 
proteins (NAPs) and are believed to be the bacterial equivalent of eukaryotic 
histones [95]. Individually, Fis is found in high concentration during the 
exponential phase due to activation of rRNA operons to accelerate fast growth. 
Its role involves response to a range of nutritional environments [96]. 
Furthermore, IHF is a sequence-specific DNA-binding protein that bends the 
DNA by over 160° [97]. It is one of the most abundant NAP during the early 
throughout late stationary phase. Lastly, H-NS regulates a variety of 
physiological functions such as metabolism, fimbriae expression, virulence 
flagella synthesis, and proper function [84] 
Auto-regulation is a common mechanism of regulation among global 
regulators. Lrp, FIS, IHF and FNR have a negative auto-regulation, frequently 
found in TFs with complex connectivity and crucial importance in regulatory 
network because of homeostatic properties [98]. 
Sigma factors 
Sigma factors are multi-domain subunits of the bacterial RNA polymerase 
(RNAP) and play an important role in transcription initiation [99]. They enable 
binding of RNA polymerase to DNA to initiate formation of the open complex 
and the initiation of the transcription. Bacteria are capable to response to a 
broad variety of environmental signals by switching on the transcription through 
a large number of sigma factors. Sigma factors are able to alter the gene 
expression to be induced or repressed by competition of different σ factors to 
bind to the core RNA-polymerase or changes in their synthesis [85, 98, 100]. 
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In E. coli, seven sigma factors has been identified and classified into two 
families based on the homologies to two σ factors: the primary factor σ70, which 
recognize most of the housekeeping gene promoters and is in charge for the bulk 
of transcription during growth and the structurally unrelated σ54 that leads 
transcription in response to environmental signals and recognize promoters of 
specific regulons involved in nitrogen regulation [99, 101]. The σ70 has ben divided 
into four groups.  Group 1, including σ70 itself, composed by sigma factors 
essential for cell growth while group 2 groups sigma factors (σs or σ38, also called 
RpoS), which is closely related to σ70 but not essential for bacterial growth. 
Group 3 and 4 includes sigma factors that control heat shock response (σ32, 
RpoH), flagellar biosynthesis and sporulation (σ28, RpoF), and extra-cellular 
stress (RpoE), respectively [84, 85, 100].  
Growth phases and transcriptional regulation  
When bacterial cells are inoculated into a fresh medium, they go through a 
growth cycle composed of four phases. As it is shown in Figure 1, when cells 
enter a new habitat and face different nutritional conditions without an increase 
of bacterial cell number is called lag phase. At this phase the cells experience a 
reprograming of the metabolic system to allow the adaptation required for 
bacterial cells to begin to explore new environmental conditions. Even thought 
this stage has not been studied extensively, it has been described that during 
this adaptation in the fresh LB medium. bacterial cells upregulate approximately 
900 genes, encoding processes such as transcription, translation, iron-sulfur 
protein assembly, nucleotide metabolism, LPS biosynthesis and aerobic 
respiration while transcription of genes related to osmotolerance, acid 
resistance, oxidative stress and adaptation to other stresses was downregulated 
[102]. Curiously, at the earliest stage of growth, there is a transient sensitivity to 
oxidative damage due to metal accumulation [103]. Promoters of the genes that 
are regulated during the lag phase exhibit a strong σ70 binding motifs [103, 104]. FIS 
is the TF remarkably expressed during the lag phase in order to activate 
promoters of ribosomal genes and it is concentrated in chromosomal zones of 
actively expressed genes [105]. Also, a dual transcriptional activator SoxS is 
significantly expressed and involved in the removal of superoxide and nitric 
oxide for protection of E. coli cell against superoxide–generating agents. The 
SoxS regulon controls 25 operons; all are involved in the production of 
metabolic energy for restart of cell growth from resting state [106]. 
 The next stage known as exponential phase or log phase is when the bacterial 
cells divide asexually by binary fission maintaining a constant rate. At this phase 
of growth, cell physiology and metabolic activity alters dramatically and this 
leads to changes in physical and chemical properties of cell components. The 
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growth rate depends on the richness of the medium. For instance E. coli growing 
at 37°C in a rich medium divide every 20 min [102]. Bacterial cell in the 
exponential phase express only one-quarter to one-third of the genes on its 
genome, while the rest of the silent genes are only expressed during adaptation 
and survival when the bacteria encounter stressful conditions [106].  
During the exponential phase, the levels of housekeeping sigma factor σ70 
reaches its peak, followed by σ28 and σ54 whereas σ38 has been reported to be 
almost undetected [85]. In early exponential phase, Fis is an abundant 
transcriptional regulator, which upregulate a large portion of genes involved in 
translation, flagellar biosynthesis and motility, nutrient transport, carbon 
compound metabolism, and energy metabolism. There is a growth phase-
dependent Fis expression, which gradually shifts its the gene expression towards 
downregulation as the cells enter stationary phase while an progressive increase 
of the CRP levels of which are inversely proportional to glucose concentration in 
the medium is observed [96]. The StpA protein is an analogous nucleoid protein 
H-NS and varies with growth phase; it is controlling the levels of σ38 at mid-
exponential phase by preventing its activation during rapid bacterial growth. In 
contrast, StpA activates the CRP-cAMP regulon during late exponential phase 
[107]. At the onset of the exponential growth, there is a significant increase in the 
rate of H2O2 production and therefore increased OxyR-dependent transcription 
to cope with the endogenous oxidative stress [108]. RpoS a major regulator 
required for adaptation to stationary phase in E. coli is also present during the 
exponential phase and participates in the regulation of genes responsible for 
carbon source transport, protein folding and iron acquisition [109].  
On the other hand, H-NS and HU (Histone-Like) have been found 
maximally expressed during this stage. H-NS in E. coli K-12 binds to the 
intrinsically curved DNA associates with genes that are thought to have been 
acquired horizontally [110]. H-NS has a negative influence on components of the 
growth-arrested regulatory machinery by maintaining GadX at its lowest levels 
and consequently preventing activation of rpoS. In addition, SoxS, MarA and Rob 
(homologous of AraC family stress response) are highly expressed [105].  
As a consequence of the high cell density, the concentration of nutrients 
depletes and waste is accumulated inducing the bacterial cells to enter to 
stationary phase (carbon starved phase), where bacteria stop dividing. 
Transcriptional ability of σ70 is diminished in a reversible manner; favoring 
alternative sigma factors i.e. σS  (encoded by rpoS gene) σ38 and σ32 (encoded by 
rpoH) [102, 106]. This switchover of transcription during starvation is carried out by 
(p)ppGpp, DksA, Rsda and 6S RNA. The action of these effectors is facilitating 
the transcription of genes involved in the maintenance of cell functions [85]. 
Changes in the culture conditions trigger activation of RpoS, the master 
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regulator of the stationary phase or stress-induced genes and involved in the 
resistance to various stress condition (e.g. oxidative stress, heat shock, osmotic 
stress, near-UV irradiation or pH changes), metabolic processes and virulence 
[102].  
Aside of stress response, RpoS regulates expression of DNA repair 
enzymes, genes involved in the cell morphology and genes encoding transport 
and binding proteins [84]. rpoS gene transcription is controlled by the cAMP 
receptor protein as well as ppGpp signaling. The transcription of rpoS increases 
as growth rate decreases while high cell density, high osmolality, phosphorus 
starvation, low temperatures and pH induce the synthesis of already present rpoS 
mRNA. Increased expression of several TFs was identified at this stage, such as 
HdfR (flagellar master regulator), McbR (sensor of quorum sensing) and NadR 
(transport and de novo synthesis of NAD) suggesting an altered metabolic system 
for energy by entry into the stationary phase [106]. The global transcriptional 
regulator Lrp plays a key role during the transition to stationary phase by 
activating proteins involved in the mobilization of internal nutrient supplies and 
to metabolize fermentation products [111]. Another regulator that contributes the 
regulation of genes at onset of the stationary phase is IHF (histone-like protein) 
is growth phase-dependent concentration and regulate genes, such as curli-
producing genes. Curli fimbriae are an essential for cell-cell contacts within 
biofilms. When the IHF levels are increased the silencing effect of H-NS is 
stopped [112]. FadR regulon is also increased during entry to stationary phase by 
controlling modulation of long-chain fatty acid pathway in order to provide 
carbon energy out of endogenous membrane digestion [113]. Changes in the 
catabolic activity were observed during this phase by regulatory response of 
ArcB/ArcA/RssB regulon [84]. Also, aerobic metabolism is repressed to prevent 
waste of energy and also as defense mechanism to avoid formation of reactive 
oxygen species by the respiratory chain [102]. While bacterial cells redirect 
metabolic circuits to scavenge nutrients and cope with the stress, other 
pathways i.e. DNA repair controlled by RpoS is downregulated due to a large 
amount of required energy leading to an increased generation of mutation [114]. 
Finally, as a consequence of accumulation of damaged molecules in starved 
cells or under certain unfavorable conditions, cells begin to program their own 
death in some cases mediated by toxin-antitoxin (TA) molecules. TA biological 
function is still in debate, but it cause the death of a part of the population, 
allowing survivors to feed with debris released from the dead cells [102].  
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Virulence gene regulation in ETEC 
As any other pathogen, ETEC is capable to sense different environmental 
stimuli and modulate the gene expression of its diverse set of virulence genes. 
Although little is known about the mechanisms behind the transcriptional 
regulation of the enterotoxins and colonization factors of ETEC, some studies 
[115-119] have identified the regulatory role of some global regulators such as CRP 
and H-NS in the modulation of LT and ST expression in response to molecules 
that may be found in the small intestine i.e. glucose and bile salts. 
Transcriptional regulation mediated by CRP  
Gene expression in bacteria has been very extensively studied showing the 
existence of global regulators, where a regulatory element controls the 
expression of many targets involved in complex cellular pathways [98]. The cAMP 
receptor protein termed CRP or catabolite activator protein (CAP) is a good 
example of global regulator in bacteria due to its control of a minimum of 378 
promoters and perhaps more than 500 genes in E. coli [120, 121]. In addition, CRP 
plays a role as ‘master’ regulator for 70 ‘slave’ transcription factors. Thus, the 
CRP manages catabolic pathways, usually in response to environmental 
conditions and specifically transports the substrates, glycolysis, the Krebs cycle, 
anaerobic respiration and also virulence [122]. CRP regulation involves promoters 
from four different σ factors and it is capable to be auto-regulated by itself in a 
positive or negative fashion [98].  
CRP has a sole effector cAMP, which is formed from the catalysis of ATP by 
a Class I adenyl cyclase (Cya) whose activity is controlled by glucose availability. 
It is known that when there is availability of glucose in the media, it is 
transported into the cell by a glucose phosphotransferase system (PTS), which 
converts glucose into glucose-6-phosphate during transport to the cytoplasm. 
The cell detects the phosphorylation state of the PTS in order to sense the 
abundance of available glucose – lower phosphorylation state of the PTS 
indicates saturation of glucose transporter, while accumulation of 
phosphorylated PTS proteins occurs when glucose is absent [122]. By 
phosphorylated PTS interaction with Cya, the adenylyl cyclase activity is 
enhanced and cAMP concentration increased; however it is also believed that 
cAMP concentration increase as a consequence of low ATP, promoting 
catabolism and turning off the anabolism [122].   
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Figure 6. Effect of the glucose in the gene expression of LT (a) and ST (b) genes.  
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The CRP-cAMP complex is capable to activate transcription by binding to 
specific DNA sequences in the promoter, often upstream of the core promoter (-
10 and -35 elements), interacting with the RNA polymerase. On the contrary, it 
can repress the expression when the binding site overlaps with or is located 
downstream of the core promoter. The consensus-binding site for CRP-cAMP is 
TGTGA-N6-TCACA and any variation in the consensus sequence affects the 
affinity of CRP-cAMP to bind to different sites.  Depending on the location of 
the binding, CRP regulation can be divided in two groups: Class I and II. Class I 
activation takes place upstream of the DNA site for RNAP, allowing interaction 
only with αCTD, which facilitate binding of RNAP to promote to form the 
RNAP-promoter closed complex [123]. At class II promoters, there is an 
overlapping site -35 element between the CRP binding site and DNA site for 
RNAP. At these promoters there are interaction protein-protein interaction 
between CRP and the RNAPα subunit either C-terminal or N-terminal domain 
that assist isomerization of the RNAP-promoter closed complex to the RNA-
promoter open complex [124]. Both mechanism allows synergistic transcription 
activation and permits “anti-activation” by negative regulators [121].  
CRP is a virulence-required regulator of several bacterial pathogens [125], 
including in ETEC [115, 116, 118]. This global regulator is involved in modulating 
the transcription of many genes in ETEC, such as colonization factors antigens 
[126] and heat-labile and heat-stable enterotoxin genes. CRP has been considered 
as a pleiotropic regulator of ETEC enterotoxins transcription [118].  
Briefly, since glucose is downregulating CRP and adelylate cyclase (the 
enzyme producing cAMP), several studies have aimed to determine the role of 
CRP and/or glucose on ETEC virulence. Early studies suggested that eltAB 
expression is inhibited by glucose [127], although addition of this carbohydrate to 
the medium supported increased LT production. Based on this controversy, 
Bodero and Munson [115] showed that in the ETEC type strain H10407, CRP 
repressed the eltAB promoter by binding to three DNA target sequences within 
the promoter region. Later, Kansal and colleagues [117] used a transcriptome in 
vivo study to suggest possible inter-strain transcriptional variation. They 
observed opposite CRP modulation of eltAB virulence genes expression using 
two different strains using two different strains H10407 and E234377A. Sahl & 
Rasko [118] and subsequently Haycocks and colleagues [116] with a more 
descriptive and robust data found an indirect repression of CRP on the eltAB and 
a differential regulation of estA1 and estA2, which might be due to occupancy of 
H-NS at target promoter sites. All this studies affirm the central role of CRP and 
the cAMP in the regulation of the enterotoxins but the complete picture of 
ETEC toxin regulation by CRP is still highly elusive and probably differs 
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between ETEC strains. The mechanisms of regulation for both toxins are 
described in Figure 6.    
Transcriptional regulation mediated by H-NS  
The histone-like nucleoid structuring protein (H-NS) is a transcriptional 
repressor and an abundant protein in E. coli (approximately 2*104 molecules per 
cell). H-NS belongs to the family of small nucleoid associated proteins together 
with FIS and IHF [87]. The structure of H-NS is formed by a N-terminal 
oligomerization domain connected to a carboxyl-terminal nucleic-acid-biding 
domain via a flexible linker [110]. For the biological activity of H-NS, the 
oligomeric state of the protein is crucial. The transcriptional repression of H-NS 
is mediated by preferentially binding to promoters exhibiting AT-rich and highly 
curved DNA region [128, 129]. Also, H-NS is able to bind to different parts of the 
same molecule of DNA or even form complexes between different DNA 
molecules such as DNA-H-NS-DNA [110, 128, 129]. Depending on the motif context 
H-NS can effect local repression or act more globally altering the packaging of 
DNA thereby silencing the packaged genes [130]. 
As the majority of the global regulators, H-NS is auto-repressed by itself 
and also repressed by the chromosomally encoded H-NS paralogue StpA while 
Fis activates hns transcription. In E. coli, H-NS levels are associated to the 
bacterial cell cycle and therefore maintain a proportional ratio of H-NS protein 
to chromosomal DNA[110].  
As CRP, H-NS has been incorporated into the virulence gene regulatory 
network and its repressor role has been investigated in bacterial pathogens such 
as EPEC [131], ETEC [132], EIEC [133], Shigella flexneri [134] and Vibrio cholerae [135]. It 
has been suggested that H-NS silences horizontally transferred genes to avoid a 
competitive disadvantage and unwelcome effect on the physiology of the 
bacterial host. However, if the new host benefits from the new genetic 
information, H-NS repression is relieved [110] as consequence of response to 
environmental cues such as temperature and osmolality by activating the 
expression of other regulators with overlapping binding sites that of H-NS [136] 
In ETEC, Yang and colleagues [137] elucidated the molecular mechanism of 
H-NS repression of eltAB by demonstrating the presence of H-NS-binding 
regions located downstream of the eltAB promoter (+31 and +110, and +460 
and +556), which were occupied by H-NS protein at 22°C. The presence of two 
binding sites indicates DNA loop formation by cooperative interaction between 
H-NS proteins bound at the two sites. Thus, RNA polymerase is excluded from 
the nucleoprotein complex formed by H-NS and DNA. Affinity of H-NS has 
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shown to be increased at 22°C indicating temperature-dependent gene 
regulation [137]. 
Another study described that not only LT gene but also STa genes (estA1 
and estA2) were subject to repression when H-NS bound to both estA1 and estA2 
promoter regions. This repression was relieved under increased osmolality. The 
mechanism suggested by Haycocks et al. [116] indicate that estA1 and estA2 
promoters are target of CRP and H-NS regulation. H-NS represses estAs 
expression probably by occluding the binding sites of CRP, the binding of RNAP 
or trapping RNA at promoter. Although was demonstrated that binding sites of 
H-NS are located within the coding sequence of the gene, oligomerization of H-
NS in surrounding DNA is necessary to prevent CRP binding. 
Bile salts 
Extracellular signal such as low pH, elevated temperature and osmolarity 
can stimulate regulator protein and promote the desire gene expression. During 
bacterial translocation through the gastrointestinal (GI) tract, they are exposed 
to a number of different potentially toxic compounds such as bile salts.   
Bile is a yellow-green aqueous solution produced by the liver and secreted 
into the upper duodenum (upper small intestine) from the bile duct. Bile is 
mainly constituted by bile salts with a concentration in the small intestine that 
ranges from 0,2 – 2% (wt/vol), depending upon the individual and the type and 
amount of food ingested. The main purpose of bile secretion is to emulsify and 
dissolve ingested fat, but a significant bactericidal effect is also achieved due to 
the detergent-like properties[138, 139].  
Several studies described the role of bile in gene expression modulation. In 
Classical Vibrio cholerae, decreased expression of CT and TcaA in about 80% was 
reported in presence of crude bile extract while motility was favored by about 
150% [140]. In transcriptome studies carried out in S. typhimurium, bile had a great 
impact on the gene expression of flagella biosynthesis [141].  
In a study using E. coli O157:H7, where the transcriptome response to bile 
was assessed, a significant upregulation of genes associated to the flagella hook-
basal body structure was found, in addition of increased levels of mRNA for 
genes associated with iron scavenging [142]. The ETEC strain E23477A was also 
subjected to a transcriptional profiling in presence of bile, showing upregulation 
of many ETEC virulence factors, including estA and eltA genes while 
downregulation was observed for the CFs CS1 and CS3 gene expression [118]. On 
the contrary our group have described that CF CS5 is upregulated in response to 
bile [143]. The same effect was found for CS7, CS17 and CS19 [144]. Thus, these 
! ! 35!
studies suggest that enteropathogens have evolved to be capable to sense and 
modulate gene expression in response of environmental signals such as bile.   
Genomic and phylogenetic relationship of ETEC  
In early studies using sequence-based PCR analysis of ETEC strains with 
restricted geographic isolation showed that strains with same toxin-CF profile 
were closely related, which provided some insights of clonal groups, which share 
same virulence genes [145]. Years later, another study based on MSLT data from 
more than thousand human ETEC isolates from different countries provided 
information about 42 different ETEC linages, which probably came from well-
established and wide-spread ETETC linages with evidence of extensive exchange 
of enterotoxin and colonization factor genes between lineages [146].  
With the arrival of the next-generation sequencing technology it became 
feasible to study hundreds of strains to help to understand the evolutionary 
process acting in ETEC populations at the whole-genome. Initially, by 
sequencing and comparing sequenced genomes of single ETEC strains (H10407, 
E24377A, B7A and clinical isolates) it was possible to identify a conserved 
genomic pathovar core for ETEC but also confirm the variability on virulence 
and antigenically dominants genes, indicating that such variability extends 
beyond the virulence genes [14, 147, 148]. 
Using the whole-genome sequencing approach we have identify signatures 
of ETEC linages from a representative collection of ETEC strains with global and 
long-term distribution [24]. The phylogenetic structure of our ETEC collection 
consisting of 363 strains placed ETEC throughout the context of the E. coli 
species (phylogroups A, B1, B2, D/E) highlighting the high genetic diversity of 
this pathovar. However, some linages of ETEC were very discrete including 
strains with similar virulence and plasmid profiles. Therefore 21 (L1-L22) ETEC 
linages were identified of which 5 appeared to be the major linages L1-L5, which 
have emerged in modern time [24]. ETEC strains from major linages expressed 
the most prevalent virulence profiles (CFA/I, CS1+CS3, CS2+CS3, CS5+CS6 
and CS6) according to previous studies. Additional analysis of the major linages 
demonstrated virulence profile pattern and this finding was also seen in the rest 
of the linages. In this sense, this study provide a framework of the structure of 
global ETEC populations based on the acquirement of plasmid encoded 
virulence factors followed by clonal spreading [24].  
In a recent study, the variation of the ETEC population during infection in 
patients was investigated by whole genome sequencing of multiple distinct 
ETEC isolates from individual patients. The identification of multiple distinct 
ETEC isolates with even heterogeneity in virulence profiles during infection 
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suggest another level of complexity where subpopulation of genomically diverse 
ETEC co-exist and causes the disease in one individual [149].  !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
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AIMS OF THE THESIS 
 
The general aim of this thesis was to study polymorphisms, expression and 
regulation of LT and ST produced by enterotoxigenic Escherichia coli (ETEC). 
Specific aims of this thesis 
• To identify single nucleotide polymorphisms (SNPs) variants in the genes 
encoding LT and ST among ETEC strains by DNA sequencing.!
• To compare the identified polymorphic sequences with phenotypic 
production of produced, and secreted toxins, and clinical characteristics 
and to evaluate whether LT and ST variants belong to different clonal 
groups or geographic origins.!
• To study the impact of host factors such glucose and bile on toxin 
expression and regulation. 
• To expand the knowledge of ETEC transcriptional gene regulation during 
bacterial growth. 
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METHODOLOGY 
 
Bacterial strains  
The University of Gothenburg has a large bacterial strain collection that 
comprises approximately 3500 enterotoxigenic Escherichia coli (ETEC) strains 
isolated worldwide, during the period of 1980 – 2014. The ETEC strains were 
collected from all age groups (children <5 years old, and adults), including 
diarrheal and asymptomatic patients, as well as from outbreak cases, adult 
travellers and soldiers visiting endemic areas. A representative selection of 362 
ETEC strains (appr. 10% of the collection) were subjected to whole-genome 
sequencing at Wellcome Trust Sanger Institute for further studies (More details 
about the ETEC strain collection are found in von Mentzer´s publication [24]). 
The strain selection criterion was based on a representative proportion of ETEC 
strains with a diverse virulence profile of toxin (only-LT, LT/ST and only-ST) 
and colonization factors and relevant geographic and temporal distribution 
including all groups of age and type of patients.   
As is represented in the Figure 7, 2 datasets were generated from the 362 
whole-genome sequenced ETEC strains based on the toxin profile. The first 
dataset is discussed in Paper I and included 186 ETEC strains expressing LT 
either alone or combined with ST. Additionally, 6 LT-expressing ETEC strains 
isolated from Bolivia during 2002-2011 were included. The second dataset 
included in Paper II contained 108 ETEC strains expressing only-ST and LT/ST. 
The toxin profiles were characterized by phenotype (inhibition ELISA for ST and 
GM1-ELISA for LT) and genotype assays (multiplex PCR for LT and ST genes) 
[144]. The CF characterization was performed by dot blot and multiplex PCR. In 
order to confirm the presence of toxin (eltAB and estA1), and CF genes, nBLAST 
gene screening was used on the ETEC genome sequences [24]. 
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In Paper IV two ETEC strains that were selected fro RNA sequencing were 
selected from the ETEC strain collection of the University of Gothenburg: E1777 
and E2265 (LT STh/CS5+CS6). Both strains were previously subjected to 
whole-genome sequencing: [13]1777 and E2265 ETEC strains were isolated from 
adult patient with diarrhea in Dhaka, Bangladesh in 2005 and 2006, respectively. 
The both belong to the global lineage 5 discussed in von Mentzer et al. [150] 
Genomic sequencing (Paper I and II)  
All the selected ETEC strains were grown on horse blood plates overnight 
at 37°C. Later, pure ETEC cultures were used to extract the DNA from each 
strain following the instructions in the Wizard Genomic DNA kit (Promega). 
The genomic library preparation and DNA sequencing performed on the 
Illumina HiSeq 2000 platform have been described by von Mentzer et al. [24].  
Figure 7. Scheme of the methodology applied in the present thesis 
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Extraction of gene sequences  
To obtain the DNA extraction of the encoding genes eltAB (LT-I), estA1 
(STp) and estA2 (STh) and type 2 Secretion System (T2SS) operon (gspC-M, pppA 
and yghG genes) from the whole genome sequencing data of each isolate, we 
used nBLAST using the respective GenBank accessory numbers are mentioned in 
Paper I, II and III. 
LT and ST variants identification and phylogenetic analysis 
For the identification of natural polymorphism at amino acid sequence 
level, we translated the extracted DNA sequence of each gene to the 
corresponding amino acid sequence using the respective reference sequence. For 
LT (Paper I) variants analysis, the signal peptides of eltA (LTA) and eltB (LTB) 
were extracted and the overlapping sequence between both genes was corrected 
resulting in a total length of 1035 nucleotides or 344 amino acids. For ST (Paper 
II) the encoding DNA sequence of 219 nucleotides was translated into a 72 
amino acids-length sequences, which formed the pre (1-19 aa) – pro (20-54 aa) – 
mature (55-72 aa) region. The multialignment analysis was performed by the 
MEGA 6,06 program separately for each enterotoxin and the sequences were 
compared to the corresponding reference sequence together with the amino acid 
sequences of previously reported LT and ST variants (accessory numbers see in 
Paper I and II). We defined a “natural variant” to when the translated target 
amino acid sequence differed in at least one amino acid sequence from the 
reference amino acid sequence.   
To establish the phylogenetic relationships of LT and ST variants a 
Neighbor-Joining (NJ) method was applied to construct the phylogenetic trees. 
NJ produces a unique final parsimonious tree minimizing the total branches 
length at each stage of clustering of OTUs (Operational Taxonomic Units) 
starting with a star-like tree. This method applies the principle of minimum 
evolution with a reliable estimation of branches lengths, and uses a relatively 
constant rate of evolution, which is suitable for analyzes of large dataset [151]. A 
bootstrap analysis (1000 replicates) was performed on the trees obtained to 
provide a confidence assessment for each clade of an observed tree, based on the 
proportion of bootstrap trees showing that same clade [152]. Phylogenetic and 
bootstrap analysis was accomplished by using MEGA 6,06 program.  
Growth conditions and culture media (Paper I - IV) 
Bacterial strains were growth onto blood horse blood plates overnight at 
37°C and then 1 colony was inoculated in 20 ml of either Luria broth (LB) for 
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LT-expressing ETEC strains or CFA medium for ST-expressing ETEC strains at 
37°C, 180 rpm during 3 h (bacterial exponential phase). The bacterial culture 
density of each strain was measured at OD600 and the adjusted volume 
(considering that 0,8 OD600 is approximately 109 bacteria) for the next inoculum 
was inoculated into 15 ml of fresh medium LB (pH=7,5) (Paper I) or CFA 
(pH=7,4) or CFA supplemented with either glucose (0,2% w/v) or bile (0,15%) 
(Paper II). Thus, the concentration of the starting cultures were always 107 
bacteria per ml medium. The cultures were subsequently incubated at 37°C, 180 
rpm for 4 h. Finally, the OD values were measured and 1 ml of bacterial cultures 
was collected to perform the GM1-ELISA and inhibition ELISA.   
For gene expression analysis, the bacterial strains were growth as 
previously described but with some modification. After inoculation of the 
adjusted volume into fresh media of either LB (only LB or supplemented with 
glucose) or CFA (only CFA, CFA supplemented with glucose or bile) (Paper II, 
III)the bacterial culture was incubated until it reached an OD600 of 0,3. A sample 
of the culture media equivalent of 108 bacteria/ml per was incubated in 
RNAprotect (Qiagen, Germany) for 5 min. The samples were centrifuged at 
10000 rpm for 10 min and the pellet was frozen at -70°C for RNA isolation.   
In Paper IV, a 10 ml LB starting culture from 10 inoculated colonies were 
diluted hundred-fold in 250 ml Erlenmeyer flask containing 20 ml of LB medium 
and incubated with aeration at 150 rpm at 37°C. After 3, 4 and 5 hours, 500 ul 
of bacterial culture was collected and mixed with as RNAprotect as described 
previously was described.  
GM1-ELISA for LT and ST toxin quantification (Paper I and II) 
First, in order to assess the produced LT among the LT variant strains we 
set up a modified and quicker GM1-ELISA using the Svennerholm & Wiklund 
[153] protocol for testing a large number of ETEC strains (Paper I). In brief, 1 ml 
of bacterial culture in LB was subjected to bacterial cell disruption using 
ultrasonication on ice and immediately transferred into the GM1-coated ELISA 
plates. The assay was performed using triplicates of each sample. The 
development and the plate reading were performed as described previously [153]. 
The data analysis was based on the extrapolation of the mean of the OD values 
from the plates read, thus OD values >0.3, 0.3 to <0.5 and ≥0.5 were 
considered as low, medium and high levels of LT produced respectively.  
Later, for the analysis of the total production and secretion of LT and ST, 
quantitative GM1-ELISA and GM1-inhibitory ELISA, respectively, were 
performed according to the previously described protocol [153]. The culture 
samples were centrifuged for 1 min at 10000 rpm and the supernatant fraction 
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was transferred to a new tube while the pellet was dissolved in 1 ml of PBS and 
the bacterial suspension was sonicated for cell disruption. Both fractions were 
analyzed for LT activity. In case of ST (Paper II), the sonication step was omitted 
and only supernatant fraction was tested for ST activity, due to that ETEC 
secretes most of the detected mature ST toxin into the supernatant. The 
concentration of LT and ST was calculated using the purified r-CTB (0.3 ug/ml) 
and ST-ref 881108 (0.3nmol/ml), respectively. The total production of LT was 
calculated by combing the concentration of LT in the pellet and supernatant 
while secretion rate (%) was obtained by dividing the concentration of LT in the 
supernatant and total production and multiplied 100.  
Another modified GM1-ELISA from Svennerholm & Wiklund [153] for LT 
detection was set up to determine the amount of free B subunit in relation with 
the AB holotoxin (Paper I). As is described in [42] two sets of monoclonal 
antibodies (mAb) were used in two different GM1-coated microtiter plates; in 
the first plate we used an in-house MAb for the detection of LTB and CTB 
(LT39:1:1) subunits whereas in the second plates we added the antibody LT17 
which detects only the A subunit of the assembled holotoxin. The next steps 
were performed according to the original protocol [153]. We based the analysis on 
the assumption that LT17 targeting anti-CTA detects the AB5 holotoxin, bound 
through the B5 subunit-mediated binding to the GM1-coated plates, while anti-
CTB detects both holotoxin and dissociated B5 subunits i.e., the total amount of 
B5 formed. The assays were performed in duplicated by measurement of the 
amounts of product in the ELISA targeting anti-CTA and anti-CTB, respectively. 
RNA extraction and cDNA preparation (Paper II, III and IV) 
The RNA isolation was performed from stored bacterial pellets in RNA 
protect RNAprotect (Qiagen, Germany) at -70°C using the RNeasy Kit (Qiagen, 
Germany). The resulting RNA was measured at 260/280 nm and by gel 
electrophoresis in 1% agarose gel. The RNA samples were stored at -70°C until 
used. The cDNA preparation was carried out using 600 ng of RNA from each 
sample using the QuantiTect cDNA kit (Qiagen, Germany). In Paper IV, RNA 
samples were precipitated carefully and RNA pellets were stored under 99,5% 
ETOH during the shipment to Beijing, China. The quality and integrity of the 
samples were re-tested upon arrival to the sequencing facility. The RNA 
Integrity Number (RIN) assessment of RNA samples gave values above 9,8 for 
all of them. Values above 8 are optimal for transcriptome sequencing. 
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Gene expression quantification of LT-I and STa by RT-PCR (Paper II and III) 
We measured the gene expression of eltAB and estA genes in LT and ST 
variant strains respectively under different conditions by quantitative real time 
PCR (qPCR). All reactions were run in 96-well plates using the standard 
amplification conditions as is described for ABI 7500 qPCR SYBR green system 
(AppliedBiosystems Foster city, CA, USA). Specific primers for STp and STh as 
well as LT-I were used [144]. The reactions were run in duplicates, and the control 
experiments (only-LB for LT and only-CFA for ST) were used as the reference 
expression levels in all experiments. The difference between the control 
experiment and the treatment experiment (LB and CFA+Glucose or CFA+Bile) 
(ΔCT) was determined and the relative expression was calculated using the 
formula 2ΔCT. The values were normalized against expression in the control 
experiment. A negative control (NTC, non template control) was included in 
each run. 
RNA-seq and data analysis (Paper IV) 
The RNA samples extracted from ETEC strains E1777 and E2265 grown LB 
collected during exponential (3h), late exponential (4h) and stationary phases 
(5h) were subject to RNA-seq analysis. The rRNA was removed using a Ribo-
Zero kit according to the manufacturer´s specification. The library construction 
was performed using the TruSeq protocol following the instructions of the 
manufacturer. Hundred base-pair reads were obtained from each library using 
standard operating procedures for the Illumina HiSeq 2000 at the Beijing 
Genome Institute (BGI), Shenzhen, China. SOAPdenovo was used for assembly 
of the short-reads and the CAP sequence assembly program (CAP3) was used to 
assembly larger contigs to create a set of non-redundant unigenes. Blast analysis 
against protein database and functional annotation of unigenes are described in 
more detail in Paper IV. Differential expression of each unigene was calculated 
using Reads Per Kilobase of transcript per Million (RPKM), which represents the 
relative expression of a transcript. The RPKM value of each gene was compared 
between the samples and only significant changes in RPKM values of more than 
2-fold (Log2>1, p<0,05) and more than 4-fold (Log2>2, p<0,05) were 
considered significant. A Poisson distribution in R was used to calculate the 
significant changes. The hierarchical clustering and heat map visualization were 
performed using R as is described in paper IV as well as additional metabolic 
profiling.   
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Statistical analysis (Paper I-IV) 
One–way analysis of variance (ANOVA) and Mann-Whitney U test were 
applied in Paper I.  Nonparametric test, Wilcoxon matched pair test was used in 
Paper II and III. P-values<0.05 were considered statistically significant. All tests 
were performed using GraphPad Prism, version 6.   ! !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
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RESULTS AND DISCUSION 
 
In this section of the thesis, the main results of the four scientific articles 
are highlighted and summarized based on similar topics and additional data not 
published are incorporated into the context to support the discussion and 
provide a more complete view of the study. 
Genetic diversity of ETEC enterotoxins  
To better understand the extent of ETEC enterotoxin gene diversity, the 
DNA sequences of the corresponding encoding genes of the heat labile (eltAB) 
and heat stable toxin (estA) expressed by human-derived ETEC strains isolated 
from children and adults with worldwide distribution and over three decades 
were studied. Originally from a whole genome sequencing data set of 362 ETEC 
strains [24] and 4 additional strains from Bolivia, 192 and 118 gene sequences of 
LT-1 (Paper I) and STa (Paper II), respectively, were selected and translated into 
amino acid sequence to be analyzed.  
It is noteworthy to mention that these are the first studies about the 
genetic diversity of the enterotoxins secreted by human derived-ETEC isolates 
isolated globally and over a longer time period. Firstly, in Paper I (also discussed 
in Paper III) the genetic variability of the heat labile toxin (LT) gene was studied 
by identifying the amino acid changes within the DNA sequence translated into 
the LTA and LTB amino acid sequence. A previous study had demonstrated 16 
polymorphic LT in a set of 51 Brazilian LT ETEC strains [41]. In Paper I we found 
12 new LT variants (LT17-LT28) from ETEC strains isolated from children and 
adults with worldwide distribution and over 31 years. In addition to the 12 new 
variants, 8 out of 16 previously described LT variants (LT1-3, LT7, LT8, LT11-
13) already reported were also found in out dataset. In total 20 LT variants were 
found among the 192 eltAB operons using multi-alignment analysis with LT1 
(expressed by the type strain H10407) as reference. Two LT variants stood out 
for being frequently identified in the LT ETEC collection, LT1 (40,6%) and LT2 
(25,8%).  
The genetic diversity of ST (Paper II) was studied to provide new insights 
about the natural heterogeneity of this toxin in the same ETEC strain collection. 
Characterization of the two types of ST, called STp and STh were performed 
using previously reported nucleotide sequences for each type (STa1 for STp and 
STa2 for STh). Ninety STh and eighteen STp sequences were identified and six 
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STa variants were discovered (STh: STa2, ST34 and a novel variant designated 
STa7; STp: STa1, and two novel variants STa5 and STa6). 
The paper by Lasaro [41] and our publication (Paper I) are the only studies 
about the genetic diversity of human LT gene. However, Zhang and Zhang [154] 
decided to analyze the diversity of LT porcine gene (LTp) in 52 porcine ETEC 
strains. LTh and LTp are up to 95% identical in the amino acid sequence and the 
data reveled little heterogeneity of LTp (1 variant). On the contrary, the related 
LT toxin, LT-II, which is not associated to human disease, is a much more 
diverse group and more divergent with 57-59% identity compared to LT-I in the 
amino acid sequence. LT-II is located in the bacterial chromosome and includes 
three variants (LT-IIa, LT-IIb and LT-IIc). A study including 50 uncharacterized 
type II ETEC strains from various sources and isolation dates displayed a 
potential variability within the LT-IIc family reporting a total of 6 variants (LT-
IIc1 – LT-IIc6) [155]. Among other AB5 toxins, such as the Shiga toxins (Stx1 and 
Stx2) several variants of Stx1 (Stx1c and Stx1d) and Stx2 (Stx2c, Stx2d, Stx2e, 
Stx2f, and Sxt2g) have been described [156, 157]. Vibrio cholerae is reported to 
express either classical type CT or biotype El Tor specific CT. Only 2 amino 
acids of the ctxB, which encodes the B subunit of CT, differ between CTBs from 
CTX phages varieties [158].    
Regarding STa variants, only one study analyzed the estA gene from 33 STa-
porcine ETEC strains and found identical sequences [154]. Another study based 
on the sequencing of the porcine heat stable toxin gene B gene (estB, STb) in 100 
porcine ETEC strains isolated over than 20 years identified the presence of only 
one variant [49]. Hence the STa and STb toxins in porcine ETEC seem to be more 
stable that STa derived from human.  
Findings of Paper I and Paper II highlight the existence of a large genetic 
diversity of human ETEC enterotoxins, which was previously reported but 
extended by our studies (Table 1). There is a large difference in number of 
variants harbored by LT (20 variants) comparing with ST (6 variants). This 
might be due to differences in terms of size, complexity, structure, function and 
immunogenicity. However, all natural variants seem to have retained virulence 
potential. When the distribution of the polymorphisms along the amino acid 
sequences of both enterotoxins were analyzed, sequences of critical regions such 
as the ADP-ribosylation active site (between 47-56 aa) in LTA and the mature 
STa toxin (18-19 aa) were highly conserved and intact, while regions located on 
the A2 helix domain of LTA and, pre- and pro- segments of ST were most 
variable.  
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We hypothesized that the amino acid variation in LT might cause instability 
during the assembly of the holotoxin, but our data using ELISA with MAbs 
targeting at LTB and the intact holotoxin did not show any difference between 
the LT2 variant that harbors 4 amino acid changes (S190L, G196D, K213E, 
S224T) comparing with LT1. Additional protein modeling of the LT1 and LT2 
structures mapped onto the crystal structure of 1LTS (LTp) did not provide new 
insights of the impact of this polymorphism on the function and structure. 
Nevertheless, the in silico modeling reveled interaction sites with potential 
protein-protein interaction (antibody-antigen) at, or nearby, polymorphic sites. 
Although these polymorphisms could potentially indicate possible advantages 
for the toxin to escape immune response others have shown that the immune 
response to LT1 and LT2 is identical [159]. 
Phylogenetic relationship of ETEC based on diversity of enterotoxins  
After the identification of several variants of the both enterotoxins, 
especially LT, we wanted to assess how these variants distribute among ETEC 
isolates. We were interested to analyze clustering with respect to virulence 
profiles, geographic isolation and phylogenetic relationship.   
Table 1. Compilation of the most prevalent virulence gene profiles of ETEC with worldwide 
distribution that resulted from the variant identification analysis in Paper I and II. 
LT variant ST variant CF profile No. 
LT1 STa3/4 CS1+CS3 (+CS21) 15 
LT1 STa3/4 CS2+CS3 (+CS21) 12 
LT1 - CS7 4 
LT1 - CS17 5 
LT1 - - 10 
LT2 STa3/4 CS5+CS6 16 
LT2 STa2 CFA/I (+CS21) 5 
LT2 - - 19 
LT8 - - 3 
LT11 - - 7 
LT11 - - 7 
LT13 - CS6 11 
LT18 STa6 CS12 3 
- STa2 CFA/I (+CS21) 14 
- STa3/4 CS1+CS3 (+CS21) 11 
- STa3/4 CS5+CS6 8 
- STa3/4 CS14 4 
- STa5 CS6 23 !
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The phylogenetic analysis of each group of LT (Paper I and Paper III) and 
ST (Paper II) sequences showed that the variants were strongly associated to the 
most prevalent CFs. The most prevalent variants of LT, LT1 and LT2 were found 
in ETEC strains expressing also CS1, CS2, CS3, and CS5+CS6, CFA/I, 
respectively. These strains also belonged to some of the most successful ETEC 
linages with global distribution [24](Paper III). Among the ST variants, all STa5 
variant strains co-expressed CS6, STa2 expressing strains co-expressed CFA/I, 
CFA/I+CS21 and CS6, STa3/4 was the most prevalent STh variant and co-
expressed 12 different combination of CFs. The complexity of the LT 
phylogenetic three confirms the level of genetic variability of the LT gene in 
contrast to the ST gene. The most frequently virulence profiles found among our 
collection of ETEC strains including the enterotoxin variant are summarized in 
Table 1 and Paper III. The data indicate that ETEC with specific and successful 
combinations of toxin variants and CFs are circulating in endemic areas causing 
a large portion of diarrheal cases. Although, we did not include epidemiological 
data of the patients with diarrhea caused by LT ETEC, we could find an 
association between STh and STp alleles (STa3/4 and STa5) with diarrheal 
disease in two different age groups of patients (children and adults, 
respectively). The expression of STa5 was associated to disease in adults while 
STa34 was associated to infant diarrhea (>5 years of age). This finding might 
indicate that some variants are prompt to cause diarrhea in specific hosts or that 
the intestinal environment in adults and children favors different toxin variants 
and/or CFs to be more successful.  
Data of the ETEC genomic linages of LT1 and LT2 ETEC strains [24] 
(discussed in Paper III) have revealed that LT variants, in particular LT1 and 
LT2, belonged to major and stable ETEC linages. For instance, a big portion of 
LT1 and LT2 strains falls into L1-L5 major linages. Altogether this data suggest 
that horizontal gene transfer is the principal vehicle of transmission and 
dispersion of successful combination of LT variants and CFs genes. The 
virulence factor combinations are probably located in compatible plasmids, 
which have advantageous traits in a specific chromosome background. Hence we 
hypothesized that both plasmids traits and chromosomal background needs to 
act in concert to generate stable and successful ETEC linages. 
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Production and secretion of ETEC enterotoxins variants  
In light of new findings we were interested in investigating the effects of 
genetic polymorphism on the phenotype by assessing the production and 
secretion of both toxin variants. As it is described in Paper I, from a screening of 
the total amount of produced LT performed in 155 ETEC strains expressing the 
main LT variants, significant differences in the levels of produced LT were 
identified, particularly between the LT1 (low producers) and LT2 (high 
producers) expressing ETEC strains. A further quantitative GM1-ELISA of LT1 
and LT2 confirmed our previous finding reporting 5-fold increased production of 
LT in LT2 variant strains compared with strains expressing LT1 variant.  
Based on our previous results, we wanted to investigate the transcriptional 
levels (mRNA) of the eltAB gene encoded by LT1 and LT2 strains (Paper III) and 
correlate with their respective phenotype (toxin production)(Paper I). Our data 
revealed slightly higher but not significantly different expression of LT2 gene 
variant compared to the LT1 gene variant. Also, variations in the amount of 
mRNA transcripts within LT variant strains were observed. One explanation of 
!
Figure 8. Diversity of CF profiles associated to LT and ST variants. The phylogenetic 
relationship representation was performed based on the amino acid sequences of the encoding 
gene of LT (a) and ST (b) using NJ method. A color pattern was used to identify the CF 
profiles and the proportion of each CF profile identified in either LT or ST variants is 
represented in pies. The area of each pie is proportional to the number of strains expressing 
the respective toxin variant.  
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these differences could be due to the levels of sensibility of both techniques and 
the sampling method. Real time PCR is a more sensitive technique than ELISA 
since fluorescent primers are used to quantify the DNA or cDNA molecules. An 
unequal sampling timing during bacterial growth in both techniques also could 
have an affect on the mRNA and protein yields. GM1-ELISA was performed with 
samples collected with an optic density of 0.8 (108 bacteria/ml) (Paper I, see 
methodology) while for Real Time PCR; the samples were taken once the optic 
density reached 0.3 (Paper III).  
The secretion levels of LT1 and LT2 were further studied. Initially the data 
of Paper I indicated comparable percentage of secreted toxin between LT1 and 
LT2 strains. By looking into the percent of LT secreted per strain, the variation 
ranged from 0 to 100%. Reports have shown fluctuation in LT secretion with 50-
fold differences among human ETEC strains grown in CAYE (supplemented 
with 0,25% glucose at pH 8,5). CAYE is a medium suggested to yield the 
highest secretion of LT in the supernatant [160, 161]. We therefore tested growth in 
LB, CAYE and CFA media on a selected set of LT1 and LT2 strains. Toxin 
production and secretion after 4 h and over night incubation (data not shown) 
indicated comparable values between CAYE and LB, while CFA did not promote 
secretion. Hence our data on LB is comparable to previous publications using 
CAYE. 
We next compared the secretion capacity of LT1 and LT2 strains that 
belonged to major ETEC lineages 1,2,3 and 5 [24]. We found that ETEC strains in 
Linage 1 and 2, that express the LT1 variant, were impaired both in production 
and secretion od the LT toxin compared to the other linages that express LT2 
(Paper III). 
Based on these findings in Paper III, we extended the analysis of the 
secretion capacity of LT1 and LT2 strains by including genomic data of the Type 
2 secretion system (T2SS) genes in order to correlate such variation in the 
secretion capacity with possible polymorphism found in genes encoding the 
T2SS (Figure 9). Once the LT toxin is assembled in the periplasm it can be 
either retained in the periplasm or secreted through the T2SS [65], or membrane 
transport machinery via vesicles to the extracellular milieu [162]. Type II secretion 
pathway is present in several proteobacteria and it is demonstrated to be 
involved in pathogenesis and to be critical for secretion of many other proteins. 
In ETEC H10407 genome two different T2SS were identified (so called T2SSα 
and T2SSβ) and they differ because alfa is not assembled in ETEC under 
standard laboratory conditions [69]. We could identify the T2SSβ in all LT1 and 
LT2 strains. A subsequent phylogenetic analysis of the genes forming the gsp 
operon was carried out, and including additional data of the secretion levels of 
LT per strain, revealed a clustering trend based on similar levels of secretion and 
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an obvious disaggregation of LT1 with respect to LT2 gsp sequences. For 
instance, the gsp operon of LT1 expressing strains branched off from the rest and 
clustered together in a cluster characterized by low levels of secretion (<34%) 
while hypersecreting (>50%) LT1 and LT2 strains grouped in different clusters. 
High values in the bootstrap test supports the sequence cluster generated [163], 
hence this data might indicate a differential secretion capacity as a consequence 
of the impact of the amino acid substitution in the Gsp proteins. Protein 
modeling and amino acid sequence analysis of LT have not reveled 
polymorphisms at the N-terminal α1 of LTB, associated to the recognition of 
secretory apparatus. So our discovery supports a previous hypothesis of variation 
of T2SS might result in different capacities of secretion.  
 
 
Figure 9. Maximum-likelihood tree of LT1 and LT2 strains based on the concatenated 
amino acid sequence of the Type 2 secretion system (T2SS) in ETEC, which includes the 
complete operon gspC-M, and pppA and yghG genes located upstream gspC. Each strain 
designation is followed by the toxin and CF profile. Numbers below-left of the nodes are 
bootstrap percentages of 1000 replicates. The corresponding levels of secretion (%) of each 
isolate were represented in green bars.  The M-L analysis was performed by MEGA6.06. 
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Along the Gsp operon, the lowest levels of polymorphisms were found in 
GspE, which is an ATPase that is thought to be essential for secretion.  
Interestingly, LT1 strains with impaired secretion had more polymorphisms in 
GspE. Also, GspC, which forms the multimeric pore for translocation of secreted 
protein, showed the highest polymorphism suggesting that GspC variants affect 
secretion levels. Obviously further studies are required for confirmation of our 
preliminary data, but altogether, this implies that polymorphisms in the T2SS is 
linked to the capability to secrete the LT toxin. 
Similar to the above studies of toxin LT production, we evaluated the 
production of the ST among the most prevalent ST variants (STa2, STa3/4 and 
STa5) strains (Paper II).  First, comparison of ST production between STh (STa2 
and STa3/4) and STp (STa1 and STa5) showed significant higher production of 
ST in STh strains.  
Next, when we examined the ST variants and we found significantly higher 
ST production in STa2 expressing strains, compared to STa3/4 and STa5 variant 
strains. Changed amino acid residues of the pre and pro regions might play a 
role in the translocation of the mature protein across the inner membrane and 
alter the efficacy of toxin translation [164]. Studies have shown that amino acid 
substitutions at position 29-31 and 37-38 within the pro region significantly 
affected the maturation pathway of STp and altered the enterotoxicity [164]. Our 
data showed that in particular, the region between position 27-35 and 37-39 
were conserved between STp and STh sequences; however amino acid changes at 
position 36 (between sequences of STh and STp), 42, 45 and 49 (only among 
STh variants) might have minor effect in the efficacy translocation of 
intermediates ST leading to conformational changes and decreasing the 
recognition of processing enzymes in the periplasm prior secretion. Also, 
alteration of amino acid with negative charge near to position 30 was shown to 
be involved in facilitating translocation of ST through the inner membrane as a 
consequence of the membrane electrical potential [165]. In our strains the charge 
near this domain was not changed.  
Until now we provided some insides about the link between the natural 
polymorphism found in LT and ST sequences with the variable capacity of ETEC 
to produce and secrete its toxin in laboratory conditions, but we believe that 
ETEC responds to a more complex scenario where fine tuning of regulation of 
the virulence genes might cause the differences of production rather that the 
mere amino acid polymorphism.  
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Transcriptional regulation of virulence in response of host factors 
As a result of coevolution between bacteria and their host and an intimate 
relation between them, bacterial pathogens are capable to employ different 
strategies to cope host defense mechanisms, to survive and multiply resulting in 
disease. ETEC has acquired a variable array of virulence factors required for the 
pathogenesis, which are interconnected to regulation systems of chromosomal 
and metabolic regulons not directly linked to pathogenesis. 
In Paper II and III we addressed questions about the role of 
gastrointestinal-related environmental signals such as glucose (for LT and ST) 
and bile (for ST) and their modulation of the toxin expression and production in 
ETEC strains that belong to different ETEC linages, in order to provide some 
hints about the influence of the host environment to the virulence of ETEC.  
Several studies have described that CRP and H-NS besides their roles of 
controlling gene expression in a global scale; also are linked to virulence [32, 115, 
116, 119]. Based on previous studies [115, 116] using H10407 as prototype to study the 
regulation of ETEC, the regulatory mechanism is described as follow: H-NS 
directly represses expression of both genes eltAB and estA by blocking the 
binding of RNAP or by sequestering RNAP at promoters. This repression is 
reverted by increasing the osmolarity and/or the temperature. CRP, on the other 
hand, acts as dual-regulator, activating transcription of estA directly and 
indirectly repressing the eltAB promoter [116]. When glucose is present, 
repression of CRP is abolished by decreased levels of intracellular cAMP and 
consequently prevented cAMP-CRP complex formation [122]; thus glucose favors 
eltAB transcription and also prevents estA expression by catabolic repression [115, 
166].  
Contrary to what was mentioned in the literature, our data of LT gene 
provides a new approach about the role of cAMP-CRP by performing in vitro 
analysis of several ETEC strains in presence of the glucose.  
Gene regulation and LT variants 
Initially, in Paper III we grew the LT1 (eltAB1) and LT2 (eltAB2) strains in 
presence and absence of glucose to compare whether gene regulation between 
LT1 and LT2 is similar or different as was observed at phenotype level. Although 
our observation showed lowered expression of LT1 and LT2 by glucose, only 
downregulation of LT1 gene was significant. Next, we analyzed the 270-
nucleotide promoter region of eltAB (peltAB) gene of LT1 and LT2 expressing 
strains in order to identify polymorphism associated to CRP binding sites. Non-
polymorphic sites were found at CRP binding sites sequences in LT1 and LT2 
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peltAB, although a SNP located at C6T within the RNAP binding position (-10) 
was frequent among LT1 strains, which showed lower gene expression. Deletion 
of CRP binding sites sequences in the peltAB promoter has shown no effect on 
CRP regulation, therefore and in agreement with Haycocks et al., [116] we also 
suggest that CRP regulation on peltAB is mediated by an intermediate unknown 
factor.  
Out data of glucose-induced expression of eltA from H10407 are in 
agreement with previous studies using the same strain. Other studies [116, 118] 
that used the ETEC model strain E24377A ETEC strain found no effect of 
glucose on the eltA expression. On the contrary, eltA from a large portion of our 
LT1 and LT2 strains were downregulated by adding glucose in the media.  Thus, 
based on our results first we support Sahl and Rasko´s observations regarding 
the need to not extrapolate the findings using only one strain since ETEC is a 
quite diverse pathovar. Moreover, our findings postulate the role of glucose as 
negative signal for transcription of eltA, and differential regulation might be 
explained by a strain-specific regulation depending on the genomic background. 
The estA gene regulation (ST) displayed a contradictory scenario than was 
observed in eltA regulation. In Paper II we analyzed the effect of bile and glucose 
on estA gene expression, since bile is an abundant compound found in the 
gastrointestinal tract and has been involved in modulating the virulence 
expression [142]. By assessing the secretion and expression of STp, STh and 
variants in presence of glucose and bile, we found that glucose has common 
pattern among ST variants characterized by decreased secretion and 
downregulation of the estA gene. Bile, on the other hand, displayed a variable 
effect, favoring the secretion of STp variant (STa5) and not affecting secretion in 
STh alleles, while downregulation of the gene expression was a general trend of 
all ST variants.  
Transcriptional regulation of ETEC related-virulence mechanism  
In Paper IV we extended the scope of ETEC regulation from assessing the 
role of specific transcription factors (Paper II and Paper III) to a global 
transcriptome scale to identify underlying mechanisms that might be related to 
the virulence during different growth phases. When the bacterium is inside of 
the host, it experiences a myriad of different stress factors e.g. nutrient 
starvation, oxidative stress and decreased growth. Some of these factors are also 
present during in vitro growth cultures when bacteria face growth transition, 
specifically from exponential to early stationary phase. We performed the LB 
transcriptome analysis during growth from mid-exponential phase to stationary 
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phase to study the global transcriptome changes and gain addiction additional 
insights into ETEC gene regulation. 
As was expected, the transcriptome data of two ETEC isolates grown for 3, 
4 and 5 hours in LB medium showed a massive variation in gene regulation of 
essential metabolic pathways and physiologic processes frequently observed 
when bacteria face reduction of nutrients in the medium. Interestingly the 
dataset that stand out also reveled a portion of genes with a peculiar pattern of 
gene regulation characterized by a significant up or down regulation at 4 hours 
with opposite trend at 3 and 5 hours of growth, described in Paper IV. This 
peculiar gene expression pattern included mechanisms involved in biofilm 
formation, indole induction, iron uptake, fucose catabolism, and the putrescine 
pathway. 
Our transcriptome dataset indicated that during the period when ETEC is 
about to enter stationary phase, mechanism such as biofilm formation and iron 
uptake are remarkably repressed, while pathways of alternative carbon (fucose) 
and nitrogen (putrescine) sources as well as signaling through indole induction 
were highly active. In a biological context, when ETEC copes with a highly 
stressful environment, this pathogen is capable to drastically regulate the gene 
expression for a certain short period of time in response to environmental 
perturbations.  
One interesting example is that the ETEC strains we analyzed in Paper IV 
(from ETEC lineage 5), seems to favor the assimilation of fucose as a carbon 
source during the transition to stationary phase. Fucose can be found in high 
concentrations in the intestinal lumen. This feature seems to reflect an 
adaptation among enteropathogens to obtain alternative carbon sources when 
the primary carbohydrates (glucose or fructose) are scarce [167, 168]. Fucose was 
also implicated in virulence by modulating virulence genes [169] and promoting 
colonization [170]. Similarly to fucose, putrescine is an alternative energy source 
abundantly found in the small intestine where the intestinal microflora are a 
major source of putrescine produced by Enterobacteriaceae spp, [171] but also it can 
be found in food contaminated by putrescine-producing strains [172]. Thus, this 
indicates that ETEC has the ability to take advantage of the commensal 
metabolism to successfully colonize the small intestine and also to be benefited 
by the diet.  
Another interesting feature in ETEC was an apparent pulse-induction of 
indole, which plays a role as a signaling molecule directly related with 
suppression of biofilm formation. The indole activation was mediated through 
regulation of TnaA (tryptophanase) that converts tryptophan to indole. The 
ETEC strains also turned off gene expression of several genes involved in biofilm 
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formation and promoted chemotaxis and motility during the transition to 
stationary phase. It suggests that biofilm formation is more likely to occur in 
later stages of bacterial growth, since the transition to stationary phase, ETEC 
seems to be more actively motile. Moreover, we observed a repression of genes 
involved in iron assimilation. Bacterial pathogens have evolved to take up and 
store iron from the host for their own survival. This mechanism was linked to 
the virulence in many other enteropathogens, but not described in ETEC yet. 
However, temporary reduction in iron uptake upon entry to stationary phase 
might indicate that ETEC uses its iron reserves to face this transition.     !
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CONCLUDING REMARKS 
 
In the present thesis we have provided new insights of the diversity of 
ETEC with focus on the enterotoxins as major virulence factors causing diarrhea 
in humans. The approaches used in this study included the analysis of different 
levels of biological complexity of ETEC. 
At amino acid sequence level: We demonstrated that the LT peptides are 
polymorphic, with several natural variants, which are described for first time in 
this study. The ST peptide is also polymorphic but to a lesser extent than LT. 
Phenotype, production and secretion of enterotoxins: Quantification of the amount 
of produced and secreted LT and ST showed that ETEC strains that express 
different toxins variants have differential capacity of production and secretion of 
their toxins and this difference could be associated to their natural 
polymorphism. 
Gene regulation of enterotoxins: By analyzing the role of CRP as a major 
regulator and the effect of glucose and bile as host factors in the transcription of 
LT and ST variants genes in several ETEC strains, we could show that CRP 
regulation on LT and ST transcription might differ between strains and toxin 
variants. A general trend showed that glucose downregulated both transcription 
and secretion of LT and ST, but this is not consistent with other reports on LT 
regulation in the literature. Bile downregulated STh expression but promoted 
STp secretion. These data indicate that there is a strain specific variation in 
response to external cues that might modulate virulence differentially. 
Genetic relationship of ETEC strains: Analysis of the relatedness of ETEC 
strains indicated that clonally related ETEC lineages harbor successful 
combinations of enterotoxins variants (LT1, LT2, STa3/4 and STa5) and 
colonization factors (CFA/I, CS1+CS3, CS2+CS3 and CS5+CS6), which allow 
them to persist over time and spread globally. 
Global transcriptome analysis of ETEC strains during growth: A framework study 
of the in vitro transcriptome was performed that provided us with new insights 
on ETEC transcriptional modulation during growth phases. ETEC in early 
stationary phase regulate distinct pathways that could have a competitive 
advantage during infection of the host. 
The disease: The data generated in this thesis gives a better understanding of 
the complexity of the underlying factors that influence the severity of the 
disease. Our results also provide a framework for further studies about the 
influence of host factors present in the human gut on ETEC virulence.
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